Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study

European Journal of Cancer

Volumn 53, Issue , 2016, Pages 115-124

  Espinosa, Pablo ^a   Pfeiffer, Ruth M ^b   García Casado, Zaida ^a   Requena, Celia ^a   Landi, Maria Teresa ^b   Kumar, Rajiv ^c   Nagore, Eduardo ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b NATIONAL CANCER INSTITUTE   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Keratinocyte skin cancer; MC1R; Melanoma; Non melanoma skin cancer; Risk factors; Second malignancy

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; CLINICAL FEATURE; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAZARD RATIO; HUMAN; KERATINOCYTE; KERATINOCYTE SKIN CANCER; MAJOR CLINICAL STUDY; MALE; MELANOCORTIN 1 RECEPTOR GENE; MELANOMA; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SKIN CANCER; SPAIN; SQUAMOUS CELL CARCINOMA; ADOLESCENT; ADVERSE EFFECTS; CANCER STAGING; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COMPLICATION; GENETICS; GENOTYPE; HAIR COLOR; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; RETROSPECTIVE STUDY; SEX RATIO; SKIN NEOPLASMS; SMOKING; SUNBURN; VERY ELDERLY; YOUNG ADULT;

MELANOCORTIN 1 RECEPTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; GENOTYPE; HAIR COLOR; HUMANS; KERATINOCYTES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; RECEPTOR, MELANOCORTIN, TYPE 1; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SKIN NEOPLASMS; SMOKING; SUNBURN; YOUNG ADULT;

EID: 84954130642     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.10.058     Document Type: Article

References (32)

1. E. Crocetti, S. Guzzinati, E. Paci, F. Falcini, R. Zanetti, M. Vercelli, and et al. The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM (the Italian Network of Cancer Registries) Melanoma Res 18 3 2008 230 234
2. F. Levi, C. La Vecchia, L. Randimbison, V.C. Te, and G. Erler Incidence of invasive cancers following cutaneous malignant melanoma Int J Cancer J Int du Cancer 72 5 1997 776 779
3. J.P. Spanogle, C.A. Clarke, S. Aroner, and S.M. Swetter Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study J Am Acad Dermatol 62 5 2010 757 767
4. R.J. van der Leest, S.C. Flohil, L.R. Arends, E. de Vries, and T. Nijsten Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis J Eur Acad Dermatol Venereol 29 6 2015 1053 1062
5. D. Scherer, and R. Kumar Genetics of pigmentation in skin cancer-a review Mutation Res 705 2 2010 141 153
6. S. Yokoyama, S.L. Woods, G.M. Boyle, L.G. Aoude, S. MacGregor, V. Zismann, and et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma Nature 480 7375 2011 99 103
7. P.A. Kanetsky, S. Panossian, D.E. Elder, D. Guerry, M.E. Ming, L. Schuchter, and et al. Does MC1R genotype convey information about melanoma risk beyond risk phenotypes? Cancer 116 10 2010 2416 2428
8. S. Raimondi, F. Sera, S. Gandini, S. Iodice, S. Caini, P. Maisonneuve, and et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis Int J Cancer J Int du Cancer 122 12 2008 2753 2760
9. C. Kennedy, J. ter Huurne, M. Berkhout, N. Gruis, M. Bastiaens, W. Bergman, and et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color J Investig Dermatol 117 2 2001 294 300
10. E. Matichard, P. Verpillat, R. Meziani, B. Gerard, V. Descamps, E. Legroux, and et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure J Medical Genetics 41 2 2004 e13
11. M.T. Landi, P.A. Kanetsky, S. Tsang, B. Gold, D. Munroe, T. Rebbeck, and et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population J Natl Cancer Inst 97 13 2005 998 1007
12. V. Hoiom, R. Tuominen, M. Kaller, D. Linden, A. Ahmadian, E. Mansson-Brahme, and et al. MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters Pigm Cell Melanoma Res 22 2 2009 196 204
13. D. Scherer, E. Nagore, J.L. Bermejo, A. Figl, R. Botella-Estrada, R.K. Thirumaran, and et al. Melanocortin receptor 1 variants and melanoma risk: a study of 2 European populations Int J Cancer J Int du Cancer 125 8 2009 1868 1875
14. D. Scherer, J.L. Bermejo, P. Rudnai, E. Gurzau, K. Koppova, K. Hemminki, and et al. MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism Int J Cancer J Int du Cancer 122 8 2008 1787 1793
15. M.T. Bastiaens, J.A. ter Huurne, C. Kielich, N.A. Gruis, R.G. Westendorp, B.J. Vermeer, and et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair Am J Human Genetics 68 4 2001 884 894
16. E. Nagore, R. Botella-Estrada, C. Requena, C. Serra-Guillen, A. Martorell, L. Hueso, and et al. Clinical and epidemiologic profile of melanoma patients according to sun exposure of the tumor site Actas dermo Sifiliogr 100 3 2009 205 211
17. Z. Garcia-Casado, V. Traves, J. Banuls, M. Niveiro, E. Gimeno-Carpio, A.I. Jimenez-Sanchez, and et al. BRAF, NRAS and MC1R status in a prospective series of primary cutaneous melanoma Br J Dermatol 172 4 2015 1128 1131
18. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Statist Assoc 94 446 1999 496 509
19. A.M. Molinaro, R. Simon, and R.M. Pfeiffer Prediction error estimation: a comparison of resampling methods Bioinformatics 21 15 2005 3301 3307
20. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 3 1988 837 845
21. R. Ihaka, and R.R. Gentlemen A language for data analysis and graphics J Comput Graph Stat 5 1996 299 314
22. S. Caini, M. Boniol, E. Botteri, G. Tosti, B. Bazolli, W. Russell-Edu, and et al. The risk of developing a second primary cancer in melanoma patients: a comprehensive review of the literature and meta-analysis J Dermatol Science 75 1 2014 3 9
23. N. Vilar-Coromina, J. Miro-Queralt, A. Cano-Bautista, L. Vilardell-Gil, P. Torres Babie, and R. Marcos-Gragera Non-melanoma skin cancer: incidence time trends analysis in Girona, Spain, 1994-2007 Medicina Clinica 137 4 2011 145 151
24. S. Rosso, R. Zanetti, C. Martinez, M.J. Tormo, S. Schraub, H. Sancho-Garnier, and et al. The multicentre south European study 'Helios'. II: different sun exposure patterns in the aetiology of basal cell and squamous cell carcinomas of the skin Br J Cancer 73 11 1996 1447 1454
25. M. Alam, and D. Ratner Cutaneous squamous-cell carcinoma N Engl J Med 344 13 2001 975 983
26. D.C. Whiteman, P. Watt, D.M. Purdie, M.C. Hughes, N.K. Hayward, and A.C. Green Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma J Natl Cancer Inst 95 11 2003 806 812
27. M. Khalesi, D.C. Whiteman, B. Tran, M.G. Kimlin, C.M. Olsen, and R.E. Neale A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin Cancer Epidemiol 37 5 2013 534 543
28. R. Marks, G. Rennie, and T. Selwood The relationship of basal cell carcinomas and squamous cell carcinomas to solar keratoses Arch Dermatol 124 7 1988 1039 1042
29. J.A. Puig-Butille, C. Carrera, R. Kumar, Z. Garcia-Casado, C. Badenas, P. Aguilera, and et al. Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population Br J Dermatol 169 4 2013 804 811
30. J.R. Doyle, J.P. Fortin, M. Beinborn, and A.S. Kopin Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways J Pharmacol Exp Ther 342 2 2012 318 326
31. T. Motokawa, T. Kato, Y. Hashimoto, and T. Katagiri Effect of Val92Met and Arg163Gln variants of the MC1R gene on freckles and solar lentigines in Japanese Pigment Cell Res 20 2 2007 140 143
32. D.C. Filitis, and M. Mahalingam Cutaneous adverse events to type I BRAF inhibitors: an analysis of effects associated with each inhibitor and therapeutic time interval to onset Am J Clin Dermatol 14 6 2013 461 471